Wilson Sonsini Goodrich & Rosati Expands Corporate and Securities Practice
- Daniel Keating Joins the Firm’s Washington, D.C., Office -
Alicia Towler White
Wilson Sonsini Goodrich & Rosati
PALO ALTO, CA (August 27, 2018) – Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Daniel Keating has joined the firm's corporate practice as a partner in the Washington, D.C., office. He will also be a member of the firm’s global generic pharmaceutical industry group.
Keating has more than 20 years of legal experience. He has focused his practice primarily on corporate and securities matters, including sophisticated domestic and international transactions. He has represented clients in mergers and acquisitions, public offerings, and financings, as well as related corporate governance matters. In particular, Keating has substantial experience representing multinational companies on cross-border M&A deals and complex commercial transactions.
Keating has worked with clients doing business in a broad range of industries. He has substantial experience working with clients in the technology, fintech, financial services, and life sciences sectors.
“Most of our clients do business not only in the U.S., but also internationally, so we know Dan’s expertise with both domestic and global transactions will complement the matters we already take on for companies and other entities we represent,” said Doug Clark, managing partner at Wilson Sonsini Goodrich & Rosati. “With Dan joining us in Washington, we continue to expand our East Coast corporate practice and strengthen our relationships with key clients, especially those in the global generics and financial industries. We look forward to working with Dan.”
Keating earned his J.D. from Georgetown University Law Center in 1996. He received his B.S. from Michigan State University in 1992, where he graduated summa cum laude. He is admitted to practice in the District of Columbia and New York.
“WSGR is a firm with an established, respected global reputation and brand for representing innovative technology and life sciences clients,” said Keating. “I’m excited about joining their corporate practice and, given my own expertise in the pharmaceuticals sector, I’m also looking forward to being a part of WSGR’s global generics industry team.”
Prior to joining WSGR, Keating was a corporate partner in an international law firm based in that firm’s Washington, D.C., office.
About Wilson Sonsini Goodrich & Rosati
For more than 50 years, Wilson Sonsini Goodrich & Rosati has offered a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among many other areas of law. With deep roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has offices in Austin; Beijing; Boston; Brussels; Hong Kong; London; Los Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; Washington, D.C.; and Wilmington, DE. For more information, please visit www.wsgr.com.